Back

Top deals dissected: Where are they now?

May 26, 2014 Tags: Biotech Business development Pharma Deals

There have been over 400 partnering deals in China in the last five years, and 85% of the pharma deals were cross-border. But what has resulted from these deals? While it's impossible to look at all 400, our panel of BD and R&D executives explore some of the partnerships they have helped put together in the last few years, from early stage academia as well as development stage deals, to see where they are now.

Moderator: Christina Zhang, JD – Cooley LLP, Shanghai